Defective renal prostaglandin synthesis in hypertensive patients with morbid obesity.
Renal prostaglandin synthesis in 36 obese hypertensive patients was estimated from measurements of 24-hour urinary prostaglandin E2 (PGE2) excretion rates. PGE2 was measured by radioimmunoassay using Dray antiserum prior to and 1 week after starting a fast supplemented by 320 cal derived from 30 g of carbohydrate, 45 g protein, and 2 g essential fatty acids. Sodium intake was 120 mEq daily or less. Comparisons were made to a control population of age-matched, nonobese, normotensive, healthy volunteers on a normal diet. Mean weight fell from 260 +/- 8 to 247 +/- 8lb, p less than 0.001. Urinary PGE2 in the obese patients prior to the fast was 104 +/- 27 ng/day, significantly lower than the 404 +/- 124 ng/day found in the control population, p less than 0.005. After the 1st week of the fast urinary PGE2 rose to 213 +/- 55, p less than 0,02. This value was not different from that in the control group. Blood pressure fell (p less than 0.001) in these patients from 143/94 +/- 3/2 to 134/87 +/- 3/2 mm Hg after the 1st week of the fast. Deficient renal prostaglandin synthesis in obese hypertensive patients was corrected by fasting. Such changes in the prostaglandin system may mediate or occur in response to changes in the sodium-volume balance of these patients. These changes in renal prostaglandin synthesis may partly contribute to the blood pressure reduction of these patients.
D001794:Blood Pressure; D001835:Body Weight; D004038:Diet, Reducing; D015232:Dinoprostone; D004231:Diuresis; D005215:Fasting; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000178:diet therapy / Q000378:metabolism*; D007668:Kidney / Q000378:metabolism*; D009318:Natriuresis; D009765:Obesity / Q000150:complications / Q000178:diet therapy / Q000378:metabolism*; D011453:Prostaglandins / Q000096:biosynthesis*; D011458:Prostaglandins E / Q000652:urine; D011863:Radioimmunoassay; D013997:Time Factors
D011453:Prostaglandins; D011458:Prostaglandins E; D015232:Dinoprostone